Notice of Closed Meeting

 
CONTENT
Federal Register, Volume 85 Issue 148 (Friday, July 31, 2020)
[Federal Register Volume 85, Number 148 (Friday, July 31, 2020)]
[Notices]
[Page 46120]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16671]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
 The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
 Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-DP21-001, Pregnancy Risk
Assessment Monitoring System (PRAMS).
 Dates: October 6, 2020-October 7, 2020, Panel A;
 October 8, 2020-October 9, 2020, Panel B
 Time: 10:00 a.m.-6:00 p.m., EDT
 Place: Teleconference.
 Agenda: To review and evaluate grant applications.
 For Further Information Contact: Jaya Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, [email protected].
 The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-16671 Filed 7-30-20; 8:45 am]
BILLING CODE 4163-18-P